Position in ABBV
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$4,596,707
+$466,137 QoQ
Shares Held
18,267
-3.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.72%
of 13F equity value
Holder Rank
#1,368
of 4,150 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WOLFF WIESE MAGANA LLC holds $14,220,884 across 12 Drug Manufacturers - General names. ABBV ranks #1 (32.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
18,267 | $4,596,707 | |
| 2 | AMGN |
Amgen Inc
|
10,938 | $3,960,868 | |
| 3 | LLY |
ELI LILLY & Co
|
2,520 | $3,022,563 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,367 | $2,360,159 | |
| 5 | JNJ |
Johnson & Johnson
|
470 | $119,365 | |
| 6 | PFE |
Pfizer Inc
|
3,854 | $92,804 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
655 | $37,741 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
149 | $18,824 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,596,707 | 18,267 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $4,130,570 | 18,992 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $4,109,392 | 17,985 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $4,111,687 | 17,758 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $3,321,298 | 17,893 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,772,198 | 18,004 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $3,215,836 | 18,097 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $3,228,205 | 16,347 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $2,693,035 | 15,701 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $2,870,078 | 15,761 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $2,507,879 | 16,183 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $2,592,898 | 17,395 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,337,565 | 17,350 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $4,271,912 | 26,805 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $4,339,713 | 26,853 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,680,574 | 27,424 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $4,191,835 | 27,369 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $4,936,735 | 30,453 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $4,112,097 | 30,370 | Shares | Defined | 2022-01-18 | |
| 2021-09-30 | $3,320,345 | 30,781 | Shares | Defined | 2021-11-01 | |
| 2021-06-30 | $3,406,232 | 30,240 | Shares | Defined | 2021-07-15 | |
| 2021-03-31 | $3,320,513 | 30,683 | Shares | Defined | 2021-04-15 | |
| 2020-12-31 | $3,207,749 | 29,937 | Shares | Defined | 2021-01-27 | |
| No filing history on record for this holder in this stock. | ||||||